Dr. Alka Chadha holds PhD in Economics from the National University of Singapore (NUS), Masters in Economics from the Delhi School of Economics, and a B.A. (Hons) in Economics from St. Stephen’s College, Delhi University. She is adjunct faculty at the Indian Institute of Management Sambalpur. She has earlier taught at NUS Business School, the National University of Singapore, and the Indian Institute of Management Tiruchirappalli.
Her teaching interests include Microeconomics, Macroeconomics, Game Theory, Health Economics. Her research areas focus on Innovation, Pharmaceuticals, Health Care, Internationalization, and FDI. She has published her work in international refereed journals including Applied Economics, World Development, Industrial and Corporate Change, Economic Modelling and Scientometrics. She is also the author of the book “Game Theory for Managers: Doing Business in a Strategic World”.
- Pattnayak, Sanja Samirana, and Chadha, Alka, (2019) “India in Global Services Value Chain: A case of IT/BPM”, Journal of Southeast Asian Economies,36(2), 204-23.
- Pattnayak, Sanja Samirana, and Chadha, Alka, (2016) “Is health care a luxury? The debate revisited with new evidence from emerging economies” Applied Economics, 48 (34), 3195-3207.
- Pattnayak, Sanja Samirana, and Chadha, Alka (2013) “Technical Efficiency of Indian Pharmaceutical Firms: A Stochastic Frontier Function Approach” Productivity: A Quarterly Journal of the National Productivity Council, April-June, 54 (1), 54-62.
- Chadha, Alka. and Oriani, Raffael. (2010) “R&D market value during weak intellectual property protection: The case of India”, Scientometrics, 82 (1), 59-74.
- Kumar, Nagesh, and Chadha, Alka (2009) “India’s outward foreign direct investments in the steel industry in a Chinese comparative perspective”, (with Nagesh Kumar, UNESCAP), Industrial and Corporate Change, 2009, 18 (2), 249-267.
- Chadha, Alka (2009) “Product cycles, innovation, and exports: A study of Indian pharmaceuticals”, World Development,37 (9), 1478-1483.
- Chadha, Alka (2009) “TRIPs and patenting activity: Evidence from the Indian pharmaceutical industry”, Economic Modelling, 26 (2), 499-505.
- “Preventive health care and Indian industry: Roles and responsibilities”, (with Ali Mehdi, ICRIER and Garima Malik, ICRIER), Journal of Health Studies, 2008, 1 (1), 24-44.
- “Destination India: The Right Choice for the Pharmaceutical Industry”, Delhi Business Review, 7(1), Jan-June 2006.
- “Exploiting the Potential of Information and Communication Technologies for Development in South Asia”, (with Nagesh Kumar), South Asian Survey,9 (2), 201-218, 2002.
- “Dollarisation Debate and its Impact for South Asia”, Mainstream, 39(31), July 21, 2001.
Game Theory for Managers: Doing Business in a Strategic World,” Second Edition, PHI Learning: New Delhi, 2020 (First Edition, 2016).
“Daiichi Sankyo’s Generic (Mis)Adventure: The Ranbaxy Takeover”, Emerald Emerging Markets Case Studies Collection, 2012, Emerald Group Publishing Limited.
- “Healthcare expenditure and income in emerging economies: The case for inclusive growth” (with Sanja Samirana Pattnayak), in Ashok Banerjee (Ed), Emerging Issues in Management: Proceedings of Pan-IIM World Management Conference 2013, Emerald India: New Delhi, 2014, pp. 117-125.
- “Role of International Monetary Fund, World Bank and Asian Development Bank in Tackling Financial Crises in Asia”, (with Sanja SamiranaPattanayak), in SeetharamKallidaikurichi (Ed), A Tale of Two Crises: A Multidisciplinary Analysis, Routledge Publication: London and New York, 2013.
- “Patent races, me-too drugs, and generics: A developing world perspective” (with Ake G. Blomqvist, Carleton University), 2005. NUS Department of Economics Working Paper No. 0513.
- “CECA Implementation: A first look”, 2006, ISAS Working Paper No. 9.
- “China’s steel industry is not stainless”, East Asia Forum, October 11, 2016.
- “Healthcare in India”, The Global Analyst, April 2015.
- “Transport key to unlock growth”, The Sunday Guardian, February 28, 2015.
- “Unfounded fears fuel plan for FDI cap in Indian pharma”, Oxford Analytica Daily Brief, August 12, 2011
- “US probe into Ranbaxy puts Indian pharma in jeopardy”, Oxford Analytica Daily Brief, February 22, 2012.
- “Free generics plan promises India major health returns” Oxford Analytica Daily Brief, February 22, 2012
Game Theory for Managers, Microeconomics, Macroeconomics, Indian Economy and Policy, Health Economics, Natural Resource Economics.
- Ph.D., Economics, National University of Singapore, Singapore.
- M.A. (Economics), Delhi School of Economics, Delhi University.
- B.A. (Hons), Economics, St. Stephen’s College, Delhi University.